Option Care Health (OPCH) Projected to Post Earnings on Wednesday

Option Care Health (NASDAQ:OPCH) is expected to issue its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $1.29 billion for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Option Care Health Stock Performance

Shares of OPCH stock opened at $32.09 on Wednesday. The stock has a fifty day moving average of $27.19 and a 200 day moving average of $27.91. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63. The firm has a market capitalization of $5.46 billion, a price-to-earnings ratio of 26.97, a PEG ratio of 2.19 and a beta of 1.35. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several recent research reports. JPMorgan Chase & Co. raised their price objective on Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. UBS Group initiated coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JMP Securities reissued a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.